The transcriptional factor E2F-1 plays a significant role in the control of cell cycle, proliferation, and carcinogenesis; a higher expression of E2F-1 is often detected in breast cancer tissues compared with normal tissues [7,8], suggesting that E2F-1 may be an effective target for treatment of breast cancer with oncolytic virus. The gene discussed is E2F1; the disease is breast cancer.